https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Angiotensin II for the treatment of vasodilatory shock https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31005 Mon 23 Sep 2019 10:08:51 AEST ]]> Selective digestive tract decontamination in critically ill adults with acute brain injuries: a post hoc analysis of a randomized clinical trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54600 Mon 04 Mar 2024 09:10:35 AEDT ]]> A Randomized Trial of Nafamostat for Covid-19 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55470 Mon 03 Jun 2024 16:14:57 AEST ]]> Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55471 Mon 03 Jun 2024 16:11:35 AEST ]]> TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55463 Mon 03 Jun 2024 10:08:13 AEST ]]>